Call us: 08045817144
Call us: 08045817144
The U.S. Food and Drug Administration approved Velpanat Tablet to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensate cirrhosis), Velpanat is approved for use in combination with the drug ribavirin. Velpanat is a fixed-dose combination tablet containing sofosbuvir, a drug approved in 2013, and Velpatasvir, a new drug, and is the first to treat all six significant forms of HCV.
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.